Clearmind Medicine Inc [NASDAQ: CMND] gained 19.00% on the last trading session, reaching $1.19 price per share at the time.
Clearmind Medicine Inc represents 5.38 million in outstanding shares, while the company has a total market value of $6.40 million with the latest information. CMND stock price has been found in the range of $1.05 to $1.31.
If compared to the average trading volume of 821.23K shares, CMND reached a trading volume of 37475571 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Clearmind Medicine Inc [CMND]:
The Price to Book ratio for the last quarter was 6.01, with the Price to Cash per share for the same quarter was set at 0.65.
Trading performance analysis for CMND stock
Clearmind Medicine Inc [CMND] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.67. With this latest performance, CMND shares gained by 20.20% in over the last four-week period, additionally plugging by 1.71% over the last 6 months – not to mention a drop of -13.77% in the past year of trading.
Clearmind Medicine Inc (CMND) Capital Structure & Debt Analysis
According to recent financial data for Clearmind Medicine Inc. ( CMND), the Return on Equity (ROE) stands at -178.64%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -66.77%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Clearmind Medicine Inc’s Return on Invested Capital (ROIC) is -380.41%, showcasing its effectiveness in deploying capital for earnings.
Clearmind Medicine Inc (CMND) Efficiency & Liquidity Metrics
Based on Clearmind Medicine Inc’s (CMND) latest financial statements, the Debt-to-Equity Ratio is 0.03%, indicating its reliance on debt financing relative to shareholder equity.
Clearmind Medicine Inc (CMND) Efficiency & Liquidity Metrics
An analysis of Institutional ownership at Clearmind Medicine Inc [CMND]
There are presently around $10.96%, or 11.27%% of CMND stock, in the hands of institutional investors.
